ethnic minorities. 1 The lower initial uptake of the GDDP among racial/ethnic minorities raises the question: why would patients who gain more from GDDPs be less likely to use them? We aimed to determine whether the uptake of the GDDP increased as the program matured and to examine whether factors affecting the uptake of the GDDP have remained steady over time. The study evaluated adults (aged >18 years) who had received at least 1 prescription drug in 2010. Users of the GDDP were defined as individuals who had used the GDDP at least once. If a prescribed medicine event had the total amount paid and days of supply equivalent to any GDDP offerings, the GDDP was coded as 1 (the coding was otherwise 0). Typical GDDP offerings were $4 for 30-day supplies and $10 for 90-day supplies as provided by Walmart, Target, and Kroger. Rite Aid, CVS, Walgreens, and Kmart had other GDDP offerings.
tors associated with use of the GDDP. The logistic regression procedure in SAS, version 9.4 (SAS Institute Inc), was used to predict probabilities for different patient groups while controlling for complex survey sampling. We assumed that all prescription drug users had an opportunity to use the GDDP. We also assumed that physician prescribing behaviors, pharmacist practice styles, and pharmacy benefit designs occurred independently of each factor affecting use of the GDDP.
Results | Of the 13 486 adults who had at least 1 prescription drug event in 2010, 3208 were GDDP users (Table) ; the weighted rate of GDDP use was 23.1%. Use of the GDDP was more likely among the elderly, sicker, and uninsured groups (Figure) . Use of the GDDP was also more likely among people living in rural areas and central regions of the United States. However, the rate of GDDP use was not significantly different across different educational level, income, and racial/ethnic groups.
Discussion | Use of the GDDP noticeably increased as the program matured. The increase may well be the result of expansion of pharmacy chains offering GDDPs and consumer awareness of the programs. As expected, GDDPs were more valued among the elderly, sicker, and uninsured populations. However, GDDPs were equally valued across different educational level, income, and racial/ethnic groups. In other words, GDDPs were not considered inferior despite the common perception that generic drugs are of poor quality. 4 In fact, GDDPs offer convenience by not requiring insurance claims to be filed. The lower use of GDDPs among racial/ethnic minorities observed when the program was deployed 1 
Use of Internist's Free Time by Ambulatory Care Electronic Medical Record Systems
Physicians complain about the time costs and other effects of electronic medical records (EMRs). [1] [2] [3] In a small survey, 4 family practice physicians reported an EMR-associated loss of 48 minutes of free time per clinic day (P < .05). We collaborated with the American College of Physicians (ACP) to revise the instrument from this study and surveyed the ACP's national sample of internists to determine the extent of this problem.
Methods | The ACP invites 1% of its members, including internal medicine attending physicians and trainees (resident and Q11. What impact, if any, has using the EMR/EHR had on your free time?
I have much more free time (eg, I get home much earlier and/or have much less patient chartand practice-related work at home) (Ask Q12) Q15. Which tasks, if any, take more of your overall time to perform using the EMR than they did before you used the computer? (Consider both the time to complete each task as well as any increase/decrease in the number of tasks. Choose all that apply.) (n = 410) 4) were attending physicians, trainees were more likely to respond. Except for the proportion of ACP members (P < .001), respondents and nonrespondents did not differ overall across 8 measured characteristics ( Table 2) . The respondents used 61 distinct EMR systems (Q4) and came from a broad range of practice types (Q1). Nine EMRs were used by 20 or more respondents, accounted for 324 (78.8%) of all users, and users of each of these lost free time (P < .05 for all). Of these 9, the Veterans Affairs' Computer Patient Record System (CPRS) was associated with the least free time loss (−20 minutes) (P = .04). Respondents were experienced EMR users. Most (70.6%) used all of the EMR functions listed in Q4, and 82.5% had EMRs in their practice for more than a year (Q7).
Among all respondents, 89.8% reported that at least 1 data management function was slower post-EMR adoption, and 63.9% reported that note writing took longer. Surprisingly, a third (33.9%) reported that it took longer to find and review medical record data with the EMR than without, and a similar proportion, 32.2%, that it was slower to read other clinicians' notes.
The mean time loss for attending physicians was −48 minutes per clinic day (P < .001), or 4 hours per 5-day clinic week. The mean loss for trainees was −18 minutes per day, less than that of attending physicians (P < .001). For the 59.4% of all respondents who did lose time, the mean loss was −78 minutes per clinic day, or 6.5 hours per 5-day clinic week.
Discussion | The loss of free time that our respondents reported was large and pervasive and could decrease access or increase costs of care. Policy makers should consider these time costs in future EMR mandates. Ambulatory practices may benefit from approaches used by high-performing practices 6 -the use of scribes, standing orders, talking instead of e-mail-to recapture time lost on EMR. We can only speculate as to whether better computer skills, shorter (half-day) clinic assignments with proportionately less exposure to EMR time costs, or other factors account for the trainees' smaller per-day time loss.
Antidepressant Dosage and Suicidal Ideation
In a recent issue of JAMA Internal Medicine, Miller and colleagues 1 proposed that the risk of a suicide attempt doubles among patients 24 years or younger if the initial prescription of selective serotonin reuptake inhibitors (SSRIs) exceeds the recommended dosage. Their findings unveiled the importance of antidepressant dosage on suicidal acts but could not take into account a key risk factor, suicidal ideation (SI), and some potential clinical confounders. Indeed, the effect of type and dosage of antidepressant on the worsening of SI at treatment onset could inform clinical decisions but has been barely studied.
Methods | The French National Medical Council approved the study, and written informed consent was obtained from each patient. We analyzed a subgroup of 767 adult outpatients included in a prospective naturalistic study 2 after the onset of antidepressant treatment for a major depressive episode. The patient's regular physician selected the antidepressant drug without restraints. Depression severity and SI were assessed through the Hospital Anxiety and Depression Scale and by item 9 of the self-rated Montgomery-Åsberg Depression Rating Scale, respectively. The participants completed these questionnaires at baseline and at weeks 1, 2, and 6. Patients were divided into 2 groups based on whether or not their SI scores increased during the follow-up period. Type of antidepressant (SSRI vs non-SSRI) and its dosage at
